Post-Market Observational Study of Intra-Renal Drug Delivery

WithdrawnOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

April 30, 2008

Conditions
Targeted Renal Therapy
Interventions
DEVICE

Targeted Renal Therapy

Patient diagnosis, treatment, and follow-up are left to the discretion of the participating investigator. There are no requisites as to how patients should be managed as this is intended to be an observational study. No procedures other than usage of the Benephit Infusion System per its Instructions for Use are specifically required for participation in this study.

Trial Locations (4)

42303

Owensboro Heart & Vascular, Owensboro

70506

Cardiovascular Institute of the South, Lafayette

92037

Scripps Clinic, La Jolla

97225

Providence Heart & Vascular, Portland

Sponsors

Lead Sponsor

All Listed Sponsors
lead

FlowMedica, Inc.

INDUSTRY